Injectable or intranasal composition comprising unstimulated or preconditioned mesenchymal stem cells (MSC), culture media derived from preconditioned MSC or exosomes derived from their culture and excipients; and its use to reduce drug use or block relapse due to withdrawal, in a person with addiction
Más información
Año de Inicio/Término: | 2017 |
DOI: |
201700237 |
Notas: | patent pending |